{"url_path":"/sec/ntrb/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1676047/0001213900-26-067840-index.html","accession_number":"0001213900-26-067840","cik":"0001676047","ticker":"NTRB","issuer_name":"NutriBand Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1676047/0001213900-26-067840-index.html","primary_entity_key":"0001676047","primary_entity_name":"NutriBand Inc."},"word_count":1282,"has_tables":true,"body_markdown":"ntrb-20260430\n\n2\nhttp://fasb.org/srt/2026#ChiefExecutiveOfficerMember\n\nQ1\nfalse\n0001676047\n--01-31\n2027\nNV\n\n0001676047\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:SubsequentEventMember\n\n2026-06-01\n\n0001676047\n\n2026-02-13\n2026-02-13\n\n0001676047\n\n2026-04-30\n\n0001676047\n\nntrb:SorrentoTherapeuticsIncMember\n\n2024-01-31\n\n0001676047\n\n2024-01-31\n\n0001676047\n\n2023-07-25\n2023-07-25\n\n0001676047\n\n2022-02-01\n2022-02-01\n\n0001676047\n\n2022-02-01\n\n0001676047\n\nntrb:KindevaDrugDeliveryLPMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:MrGoodmanMember\n\n2022-07-31\n\n0001676047\n\nsrt:ChiefFinancialOfficerMember\n\n2026-04-30\n\n0001676047\n\n2022-07-31\n\n0001676047\n\nus-gaap:ReportableSubsegmentsMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:ReportableSubsegmentsMember\n\n2026-04-30\n\n0001676047\n\nntrb:FourPTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-01-31\n\n0001676047\n\nntrb:FourPTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-04-30\n\n0001676047\n\nntrb:PoconoPharmaceuticalsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-01-31\n\n0001676047\n\nntrb:PoconoPharmaceuticalsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:CorporateAndOtherMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:CorporateAndOtherMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-04-30\n\n0001676047\n\ncountry:US\nus-gaap:ReportableSubsegmentsMember\n\n2026-01-31\n\n0001676047\n\ncountry:US\nus-gaap:ReportableSubsegmentsMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\ncountry:US\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\ncountry:US\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:FourPTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:FourPTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:PoconoPharmaceuticalMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:PoconoPharmaceuticalMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:ResearchAndDevelopment4PTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:ResearchAndDevelopment4PTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:SellingGeneralAndAdministrativeCorporateMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:SellingGeneralAndAdministrativeCorporateMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:SellingGeneralAndAdministrative4PTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:SellingGeneralAndAdministrative4PTherapeuticsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:SellingGeneralAndAdministrativePoconoPharmaceuticalsMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:SellingGeneralAndAdministrativePoconoPharmaceuticalsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesFourteenMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesFourteenMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesThirteenMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesThirteenMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesTwelveMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesTwelveMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesElevenMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesElevenMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesTenMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesTenMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesNineMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesNineMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesEightMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesEightMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesSixMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesSixMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesFiveMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesFiveMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesFourMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesFourMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesThreeMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesThreeMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesTwoMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesTwoMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesOneMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:StockOptionMember\nntrb:ExercisePricesOneMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2025-02-01\n2026-01-31\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-31\n2025-01-31\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-31\n\n0001676047\n\nsrt:MaximumMember\nus-gaap:EmployeeStockOptionMember\n\n2025-02-01\n2026-01-31\n\n0001676047\n\nsrt:MinimumMember\nus-gaap:EmployeeStockOptionMember\n\n2025-02-01\n2026-01-31\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2025-02-01\n2026-01-31\n\n0001676047\n\nsrt:MaximumMember\nsrt:ChiefExecutiveOfficerMember\n\n2026-01-31\n\n0001676047\n\nsrt:MinimumMember\nsrt:ChiefExecutiveOfficerMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-31\n\n0001676047\n\nsrt:MaximumMember\nus-gaap:EmployeeStockOptionMember\n\n2024-03-20\n\n0001676047\n\nsrt:MinimumMember\nus-gaap:EmployeeStockOptionMember\n\n2024-03-20\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2021-11-03\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2021-11-01\n2021-11-01\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2023-02-01\n2023-02-01\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2022-02-01\n2022-02-01\n\n0001676047\n\nus-gaap:EmployeeStockOptionMember\n\n2021-11-01\n\n0001676047\n\nus-gaap:WarrantMember\n\n2026-04-30\n\n0001676047\n\nntrb:ExercisePrices750Member\nus-gaap:WarrantMember\n\n2026-04-30\n\n0001676047\n\nntrb:ExercisePrices750Member\nus-gaap:WarrantMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:ExercisePrices643Member\nus-gaap:WarrantMember\n\n2026-04-30\n\n0001676047\n\nntrb:ExercisePrices643Member\nus-gaap:WarrantMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:ExercisePriceSixPointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-04-30\n\n0001676047\n\nntrb:ExercisePriceSixPointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:ExercisePriceFourPointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-04-30\n\n0001676047\n\nntrb:ExercisePriceFourPointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:WarrantMember\nntrb:ExercisePricesThreePointSevenThreeMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:WarrantMember\nntrb:ExercisePricesThreePointSevenThreeMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:WarrantMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:WarrantMember\n\n2025-02-01\n2026-01-31\n\n0001676047\n\nus-gaap:WarrantMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:WarrantMember\n\n2025-01-31\n2025-01-31\n\n0001676047\n\nus-gaap:WarrantMember\n\n2025-01-31\n\n0001676047\n\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001676047\n\nus-gaap:WarrantMember\n\n2025-09-30\n\n0001676047\n\nus-gaap:CommonStockMember\nus-gaap:WarrantMember\n\n2025-02-01\n2025-02-28\n\n0001676047\n\nntrb:ConsultantMember\nus-gaap:CommonStockMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:TreasuryStockCommonMember\n\n2025-03-04\n\n0001676047\n\n2025-04-30\n\n0001676047\n\nsrt:MaximumMember\n\n2022-08-04\n\n0001676047\n\nsrt:MinimumMember\n\n2022-08-04\n\n0001676047\n\nsrt:DirectorMember\n\n2022-07-26\n2022-07-26\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2025-07-09\n2025-07-09\n\n0001676047\n\nus-gaap:SeriesAPreferredStockMember\n\n2025-07-09\n2025-07-09\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2025-07-09\n\n0001676047\n\nus-gaap:SeriesAPreferredStockMember\n\n2025-07-09\n\n0001676047\n\nus-gaap:SeriesAPreferredStockMember\nus-gaap:CommonStockMember\n\n2025-07-09\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2016-01-15\n\n0001676047\n\nsrt:ChiefExecutiveOfficerMember\n\n2026-04-30\n\n0001676047\n\n2026-01-31\n\n0001676047\n\nus-gaap:IntellectualPropertyMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:IntellectualPropertyMember\n\n2026-04-30\n\n0001676047\n\nntrb:CustomerBaseMember\n\n2026-01-31\n\n0001676047\n\nntrb:CustomerBaseMember\n\n2026-04-30\n\n0001676047\n\nntrb:SecuredBorrowingLiabilityMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:SecuredBorrowingLiabilityMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:SecuredBorrowingLiabilityMember\n\n2023-07-19\n\n0001676047\n\nntrb:NotePayableRelatedPartyMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:NotePayableRelatedPartyMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:NotePayableRelatedPartyMember\n\n2026-01-31\n\n0001676047\n\nntrb:NotePayableRelatedPartyMember\n\n2026-04-30\n\n0001676047\n\nntrb:NotePayableRelatedPartyMember\n\n2024-05-15\n\n0001676047\n\nntrb:NotePayableRelatedPartyMember\n\n2024-02-01\n2024-10-31\n\n0001676047\n\nntrb:NotePayableRelatedPartyMember\n\n2023-07-17\n\n0001676047\n\nus-gaap:LineOfCreditMember\nntrb:NotePayableRelatedPartyMember\n\n2023-07-17\n\n0001676047\n\nntrb:AutomobileMember\n\n2026-01-31\n\n0001676047\n\nntrb:AutomobileMember\n\n2026-04-30\n\n0001676047\n\nntrb:AutomobileMember\n\n2022-04-03\n2022-04-03\n\n0001676047\n\nntrb:AutomobileMember\n\n2022-04-03\n\n0001676047\n\nus-gaap:LineOfCreditMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:LineOfCreditMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:LineOfCreditMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:CostOfGoodsSoldMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:CostOfGoodsSoldMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:FurnitureAndFixturesMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:FurnitureAndFixturesMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:MachineryAndEquipmentMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:MachineryAndEquipmentMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:EquipmentMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:EquipmentMember\n\n2026-04-30\n\n0001676047\n\nntrb:PoconoCoatedProductsLLCAndActiveIntelligenceLLCMember\n\n2020-08-31\n\n0001676047\n\nntrb:FourPTherapeuticsLLCMember\n\n2026-04-30\n\n0001676047\n\ncountry:US\n\n2025-02-01\n2025-04-30\n\n0001676047\n\ncountry:US\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:SaleOfGoodsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:SaleOfGoodsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nntrb:CustomerDMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nntrb:CustomerCMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nntrb:CustomerBMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nntrb:CustomerAMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:CreditLineNoteFacilityMember\n\n2024-04-19\n2024-04-19\n\n0001676047\n\nus-gaap:RelatedPartyMember\nntrb:CreditLineNoteFacilityMember\n\n2023-07-17\n\n0001676047\n\nus-gaap:RelatedPartyMember\nntrb:CreditLineNoteFacilityMember\n\n2023-03-31\n\n0001676047\n\nntrb:PoconoPharmaceuticalsMember\n\n2020-08-31\n\n0001676047\n\n2018-08-01\n\n0001676047\n\nntrb:FourPTherapeuticsLLCMember\n\n2018-08-01\n\n0001676047\n\nus-gaap:CommonStockMember\nntrb:FourPTherapeuticsLLCMember\n\n2018-08-01\n\n0001676047\n\nus-gaap:CommonStockMember\nntrb:FourPTherapeuticsLLCMember\n\n2018-08-01\n2018-08-01\n\n0001676047\n\n2025-01-31\n\n0001676047\n\nus-gaap:TreasuryStockCommonMember\n\n2025-04-30\n\n0001676047\n\nus-gaap:RetainedEarningsMember\n\n2025-04-30\n\n0001676047\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-04-30\n\n0001676047\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-04-30\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2025-04-30\n\n0001676047\n\nus-gaap:RetainedEarningsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:TreasuryStockCommonMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:TreasuryStockCommonMember\n\n2025-01-31\n\n0001676047\n\nus-gaap:RetainedEarningsMember\n\n2025-01-31\n\n0001676047\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-01-31\n\n0001676047\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-31\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2025-01-31\n\n0001676047\n\nus-gaap:TreasuryStockCommonMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:RetainedEarningsMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:RetainedEarningsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:TreasuryStockCommonMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:RetainedEarningsMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2026-01-31\n\n0001676047\n\n2026-06-11\n\n0001676047\n\nntrb:Warrants1Member\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2025-01-31\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nntrb:GoodwillAndIntangiblesImpairmentMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nntrb:GoodwillAndIntangiblesImpairmentMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:CorporateAndOtherMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:CorporateAndOtherMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:NonUsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:NonUsMember\nus-gaap:ReportableSubsegmentsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:NonUsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-04-30\n\n0001676047\n\nus-gaap:NonUsMember\nus-gaap:ReportableSubsegmentsMember\n\n2026-01-31\n\n0001676047\n\nus-gaap:ServiceMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:ServiceMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:NonUsMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:NonUsMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:CommonStockMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:TreasuryStockCommonMember\n\n2026-02-01\n2026-04-30\n\n0001676047\n\nus-gaap:RelatedPartyMember\n\n2025-02-01\n2025-04-30\n\n0001676047\n\nus-gaap:PreferredStockMember\n\n2025-04-30\n\niso4217:USD\n\nutr:sqft\n\nxbrli:pure\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:shares\n\nntrb:Segment\n\n \n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C.\n\n \n\nFORM 10-Q\n\n \n\n☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the quarterly period ended April 30, 2026\n\n \n\nOR\n\n \n\n☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the transition period from __________ to __________\n\n \n\nCommission File Number 000-40854\n\n \n\nNUTRIBAND INC.\n\n(Exact name of registrant as specified in its charter)\n\n \n\nNEVADA 81-1118176\n\n(State or other jurisdiction of\n\nincorporation or organization)\n \n(I.R.S. Employer\n\nIdentification No.)\n\n \n\n121 South Orange Ave., Suite 1500, Orlando, FL 32801\n\n(Address of Principal Executive Offices)\n \n(Zip Code)\n\n \n\n(407) 377-6695\n\n(Registrant’s Telephone Number, Including\nArea Code)\n\n \n\nSecurities registered pursuant to Section 12(b)\nof the Act:\n\n \n\nTitle of each class\n \nTrading Symbol(s)\n \nName of each exchange on which registered\n\nCommon Stock  NTRB  The Nasdaq Stock Market LLC \n\nWarrants NTRBW The Nasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒  No ☐\n\n \n\nIndicate by check mark whether the registrant\nis a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.\nSee the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer\n☐\nAccelerated filer\n☐\n\nNon-accelerated filer☒Smaller reporting company☒\n\n Emerging growth company☒\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nThe number of shares outstanding of the issuer’s common stock, par value $0.001 per share, was 12,155,983 shares as of June 11, 2026\n\n \n\n \n\n \n\n \n\nNUTRIBAND INC.\n\n \n\nINDEX\n\n \n\n \n \n \nPage No.\n\n[Part I: Financial Information](#a_002)\n \n1"}